FIRST AMENDMENT TO THE LICENSE AGREEMENTThe License Agreement • May 14th, 2024 • Arcutis Biotherapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 14th, 2024 Company Industry JurisdictionTHIS FIRST AMENDMENT TO THE LICENSE AGREEMENT (this “Amendment”) is made as of [●], 2024 (the “Amendment Effective Date”), by and between Arcutis Biotherapeutics, Inc. (“Arcutis”) and Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd (“Huadong”). Capitalized terms used herein but not defined herein shall have the same meaning as set forth in the License Agreement (as defined below). Each of Arcutis and Huadong may be referred to herein as a “Party” or together as the “Parties.”
Contract1 License Agreement This License Agreement • May 14th, 2024 • Arcutis Biotherapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 14th, 2024 Company Industry Jurisdiction